CER low impact; Big Data In-patient MR; FDA continuing Mini-Sentinel? (PRVR–7/28-31/2014)

This week on Pharma Research VIDEO Report:
1) Experts agree the promise of comparative effectiveness research is having very little impact on healthcare decision making. 2) Dr. David Bates researched Big Data algorithms that he says can positively impact the expenditures on low-hanging fruit with in-patients. 3) The FDA must make a decision on whether or not to continue Mini-Sentinel, a program that queries 18 health plan and insurance partners about patient records that can show adverse events.

We want to hear from you

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,748 other followers

%d bloggers like this: